Source: PharmacoEconomics and Outcomes News, Volume 1, Number 551, 2008-04-19 , pp. 5-5(1)
Publisher: Adis International
Keywords: Cognitive-behavioural-therapy; Cost-effectiveness; Irritable-bowel-syndrome, treatment; Mebeverine, therapeutic use
Document Type: Research article
Links for this article